Search research articles
Contact Us
Filters
Showing results (141-150 of 251) with videos related to
Page
of 26
Sort By:
Journal of Medicinal Chemistry
|
September 21, 2001
Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies
Y Fan, L M Shi, K W Kohn, et al.
Cancer Research
|
March 15, 1989
Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity
C Jaxel, K W Kohn, M C Wani, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2000
Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs
D M Voeller, J L Grem, Y Pommier, et al.
Virology
|
May 12, 1997
Host site selection for concerted integration by human immunodeficiency virus type-1 virions in vitro
G Goodarzi, R Chiu, K Brackmann, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
February 18, 1980
[Very long survivals of chronic granulocytic leukemia (author's transl)]
J Debray, Y Pommier, A A Audebert, et al.
Cancer Research
|
September 15, 1993
bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair
S Kamesaki, H Kamesaki, T J Jorgensen, et al.
Biochemical Pharmacology
|
June 22, 1993
Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent
E Solary, F Leteurtre, K D Paull, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1997
A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine
B C Baguley, F Leteurtre, J F Riou, et al.
Molecular Pharmacology
|
July 1, 1990
Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II
K Wassermann, J Markovits, C Jaxel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide
B K Sinha, P M Politi, H M Eliot, et al.
Page
of 26
Search research articles
Search
Showing results (141-150 of 251) with videos related to
Sort By:
Page
of 26
Journal of Medicinal Chemistry
|
September 21, 2001
Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies
Y Fan, L M Shi, K W Kohn, et al.
Cancer Research
|
March 15, 1989
Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity
C Jaxel, K W Kohn, M C Wani, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2000
Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs
D M Voeller, J L Grem, Y Pommier, et al.
Virology
|
May 12, 1997
Host site selection for concerted integration by human immunodeficiency virus type-1 virions in vitro
G Goodarzi, R Chiu, K Brackmann, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
February 18, 1980
[Very long survivals of chronic granulocytic leukemia (author's transl)]
J Debray, Y Pommier, A A Audebert, et al.
Cancer Research
|
September 15, 1993
bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair
S Kamesaki, H Kamesaki, T J Jorgensen, et al.
Biochemical Pharmacology
|
June 22, 1993
Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent
E Solary, F Leteurtre, K D Paull, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1997
A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine
B C Baguley, F Leteurtre, J F Riou, et al.
Molecular Pharmacology
|
July 1, 1990
Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II
K Wassermann, J Markovits, C Jaxel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide
B K Sinha, P M Politi, H M Eliot, et al.
Page
of 26